Skip to main content

Table 2 VAS before administration of treatments and 3, 6 and 12 months afterwards

From: Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis

Time

PRP

BM-MSCs + PRP

Baseline

5 (1.8)

5.3 (1.9)

3 months

3.8 (1.6)*

3.8 (2)*

6 months

3.5 (2)*

3.3 (2.2)*

12 months

4.5 (2.2)

3.5 (2.5)**

  1. Data are presented as mean (SD). Intragroup comparisons between follow-up values and baseline values: *p < 0.05; **p = 0.01
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us